Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
OPINION
Full Access
full
Viewing teratogens through the lens of nicotinamide adenine dinucleotide (NAD+)
- Pages: 1313-1323
- First Published: 17 September 2022
REVIEW ARTICLES
Full Access
full
Prenatal epigenetic factors are predisposing for neurodevelopmental disorders—Considering placenta as a model
- Pages: 1324-1342
- First Published: 13 November 2022
Full Access
full
Delineating septo-optic dysplasia
- Pages: 1343-1353
- First Published: 06 October 2022
RESEARCH ARTICLES
Full Access
full
Genetic evaluation of HAND2 gene and its effects on thalidomide embryopathy
- Pages: 1354-1363
- First Published: 30 September 2022
Full Access
full
Reduction of infant mortality from congenital heart defects in a middle-income country: Costa Rican experience
- Pages: 1364-1375
- First Published: 29 September 2022
Full Access
full
Final results from the ribavirin pregnancy registry, 2004–2020
- Pages: 1376-1391
- First Published: 28 October 2022
Full Access
full
A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects
- Pages: 1392-1403
- First Published: 07 November 2022
Open Access
oa
Prevalence of congenital heart defects in Europe, 2008–2015: A registry-based study
- Pages: 1404-1416
- First Published: 08 November 2022
Open Access
oa
Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries
- Pages: 1417-1426
- First Published: 11 November 2022
Open Access
oa
Amelia and phocomelia in Finland: Characteristics and prevalences in a nationwide population-based study
- Pages: 1427-1433
- First Published: 09 November 2022
SHORT COMMUNICATION
Full Access
full
Differential newborn DNA methylation among individuals with complex congenital heart defects and childhood lymphoma
- Pages: 1434-1439
- First Published: 13 October 2022
CASE REPORT
Full Access
full
Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues
- Pages: 1440-1448
- First Published: 08 November 2022